YS Company Reputation Risk Management For Remicade Patient Assistant Program

Newly patented drugs generally perform better in terms of efficacy and side effects,however the prices are also much more expensive.In the course of disease treatment,many patients' families became poor caused by illness.In order to let more patients can accept standard treatment,many multinational pharmaceutical companies bring Patient Assistant Program(PAP is called for short below)to China,by cooperating with domestic charitable foundation.According to the help of PAP,Chinese low-income patients can accept the high price of medicine treatment.Recently,more and more high-priced patent drugs,even some high-priced generic drugs,have been using PAP to help low-income patients to improve the economic accessibility of drug treatment.The implementation of the PAP is directly related to the patient's life safety,and also related to the enterprise reputation that pharmaceutical enterprises have promised in the public charity project.It has the characteristics of charity,complexity,dynamics and high risk,which brings difficulties and challenges to the reputation risk management of pharmaceutical enterprises.From the current research status,there is no related enterprise's reputation risk management research of PAP can be directly used for reference.Remicade PAP,with a large number of patients,high operating costs,strict distribution process,involving many related companies,is the YS company's largest and most complex social responsibility public charity project so far.I hope to establish the reputation management and control sYStem for Remicade PAP through the reputation risk research,so as to reduce or avoid the enterprise reputation risk.The overall structure of this paper is as follows: the introduction elaborates the research background,significance and current status of reputation risk research.The second chapter introduces the concepts and theories related to corporate reputation risk management,clarifies the connection and difference between corporate reputation risk and corporate risk,and introduces the corporate risk management methods used in this research.Research methods include risk identification,risk assessment,risk response and risk monitoring.In the third chapter: Program introduction,implementation status,reputation risk management objectives and major risk items analysis.The fourth chapter: Using the research method of enterprise risk management,risk identification and risk assessment are carried out for 5 kinds of reputation risk items one by one.In the fifth chapter: The author conducted a risk response and risk control study on the five kinds of risk items.Thus,the enterprise reputation risk of YS company's PAP was optimized After risk warning indicators,trigger warning standards and reputation risk management workflow are all established.In the sixth chapter: According to the research results,the reputation risk management and control sYStem of Remicade PAP was established,including the overall early-warning indicators setting and risk control workflow setting.After this sYStem implemented for five months,through the questionnaire survey from both project service personnel and donated patients,the implementation effect of reputation risk management and control sYStem was understood,and the practicality was preliminarily evaluated in helping the optimization and improvement of YS company's reputation risk management.In the conclusion part: The author summarizes the research results,introduces the creativity,application prospect and social value of the research results,and forecasts the follow-up research.According to the survey results after implemented for five months,YS company's Remicade PAP's reputation risk management s YStem is evaluated to be useful for reputation risk management.